Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis,...

There is only a short window of opportunity to seek medical help before rabies becomes almost invariably fatal, but people wait an average of 10 days before seeking medical advice following exposure to...

A study by the University of Southampton shows that several low-and middle-income countries, especially in Africa, need more effective child vaccination strategies to eliminate the threat from vaccine-preventable...

A collaborative team from The University of Texas Medical Branch at Galveston, Saudi Arabia and Canada developed a potent and safe vaccine that protects against the deadly Middle East respiratory syndrome,...

Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announced today it will present on its Lyme disease and chikungunya vaccine candidates...

The CDC recently reported 465 measles cases in 19 states across the country, including seven outbreaks. This is the second-greatest number of cases reported in the U.S. since measles was eliminated in...

A research team led by scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that...

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers....

The human cost of not getting vaccinated is well known–measles, diphtheria and other outbreaks reported across the globe. All very unnecessary. The history of the success of vaccines is well documented- Nearly...

The bivalent Norovirus GII.4 oral tablet vaccine developed by Vaxart is moving forward–the initiation of a Phase 1b clinical trial. “The initiation of the bivalent norovirus vaccine Phase 1b trial...